14th Annual Western AF Symposium Agenda

Western A-Fib Symposium prides itself on a dynamic and supremely current agenda with leading experts. For this reason, the program is continually transforming as it incorporates breaking updates in the field. You are welcome to check this document up to the program date for such changes.

Please note that all faculty have been asked to submit disclosures of all potential conflicts of interest that arise from financial relationships with a commercial interest(s). (A commercial interest is defined as any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients.) All such disclosures are noted under the ‘Faculty’ tab on this website.

Thursday, February 25, 2021

 

17:30-19:30RECEPTION & PRESENTATIONS BY TOP EP FELLOW SCHOLARSHIP CONTESTANTS
Hosted by Medtronic

Thursday, February 25, 2021

 

17:30-19:30
RECEPTION & PRESENTATIONS BY TOP EP FELLOW SCHOLARSHIP CONTESTANTS
Hosted by Medtronic

Friday, February 26, 2021

 

07:00 – 07:30REGISTRATION, EXHIBITS & BREAKFAST SNACKS
07:30 – 07:45WELCOME & INTRODUCTIONS
Nassir F. Marrouche, MD

Friday, February 26, 2021

 

07:00 – 07:30
REGISTRATION, EXHIBITS & BREAKFAST SNACKS
07:30 – 07:45
WELCOME & INTRODUCTIONS
Nassir F. Marrouche, MD

Session 1

Chairs: Hugh Calkins, MD; Melvin Scheinman, MD

07:45 – 07:55ATRIAL FIBRILLATION: MAJOR BREAKTHROUGHS OF 2020
Eric N. Prystowsky, MD 
07:55 – 08:05HOW MACHINE LEARNING IS TAKING OVER STRATEGIES FOR AF SCREENING
Hamid Ghanbari, MD
08:05 – 08:15THE NEW ESC 2020 AF GUIDELINES
Gerhard Hindricks, MD, MBA, ProfDr.
08:15 – 08:25HOW I CHANGED MY PRACTICE AFTER EAST-AF
John Mandrola, MD
08:25 – 08:35INTEGRATING DIGITAL DATA INTO CLINICAL PRACTICE DURING A PANDEMIC: TIPP & WEAICOR
Lilas Dagher, MD
08:35 – 08:55OPEN DISCUSSION
Session 1

Chairs: Hugh Calkins, MD; Melvin Scheinman, MD

07:45 – 07:55
ATRIAL FIBRILLATION: MAJOR BREAKTHROUGHS OF 2020
Eric N. Prystowsky, MD
07:55 – 08:05
HOW MACHINE LEARNING IS TAKING OVER STRATEGIES FOR AF SCREENING
Hamid Ghanbari, MD
08:05 – 08:15
THE NEW ESC 2020 AF GUIDELINES
Gerhard Hindricks, MD, MBA, ProfDr.
08:15 – 08:25
HOW I CHANGED MY PRACTICE AFTER EAST-AF
John Mandrola, MD
08:25 – 08:35
INTEGRATING DIGITAL DATA INTO CLINICAL PRACTICE DURING A PANDEMIC: TIPP & WEAICOR
Lilas Dagher, MD
08:35 – 08:55
OPEN DISCUSSION

Session 2

MODERATORS: Ahmad Abdul-Karim, MD; Gregory F. Michaud, MD

08:55 – 09:55ROUNDTABLE: MY INITIAL APPROACH TO PATIENTS WITH PERSISTENT AF:
NO TRIALS SUPPORTING MORE THAN PVI

Mikhael El-Chami, MD, FHRS; Uzodinma Emerenini, MD; Alexies Ramirez, MD, FHRS; Gaston R. Vergara, MD
09:55 – 10:10BREAK & EXHIBITS
Session 2

MODERATORS: Ahmad Abdul-Karim, MD; Gregory F. Michaud, MD

08:55 – 09:55
ROUNDTABLE: MY INITIAL APPROACH TO PATIENTS WITH PERSISTENT AF:
NO TRIALS SUPPORTING MORE THAN PVI

Mikhael El-Chami, MD; Uzodinma Emerenini, MD; Alexies Ramirez, MD, FHRS; Gaston R. Vergara, MD
09:55 – 10:10
BREAK & EXHIBITS

Session 3

CHAIRS: Roger A. Freedman, MD; Christian Mahnkopf, MD

10:10 – 10:20EPI/ENDO ABLATION FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION: THE ‘CONVERGE’ TRIAL
David D. De Lurgio, MD, FACC, FHRS
10:20 – 10:30HOW MUCH AF GETS MY ATTENTION? THE BURDEN LESSON
Jeanne E. Poole, MD
10:30 – 10:40PULSED FIELD ABLATION: THE PHYSICS
David E. Haines, MD
10:40 – 10:50ICE-GUIDED LEFT ATRIAL APPENDAGE CLOSURE IMPLANTATION: FEASIBILITY
Walid Saliba, MD
10:50 – 11:15OPEN DISCUSSION
11:15 – 12:30LUNCH & EXHIBITS
Session 3

CHAIRS: Roger A. Freedman, MD; Christian Mahnkopf, MD

10:10 – 10:20
EPI/ENDO ABLATION FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION: THE ‘CONVERGE’ TRIAL
David D. De Lurgio, MD, FACC, FHRS
10:20 – 10:30
HOW MUCH AF GETS MY ATTENTION? THE BURDEN LESSON
Jeanne E. Poole, MD
10:30 – 10:40
PULSED FIELD ABLATION: THE PHYSICS
David E. Haines, MD
10:40 – 10:50
ICE-GUIDED LEFT ATRIAL APPENDAGE CLOSURE IMPLANTATION: FEASIBILITY
Walid Saliba, MD
10:50 – 11:15
OPEN DISCUSSION
11:15 – 12:30
11:30 – 12:15

MEET THE EXPERTS

0.75ROLE OF NON-PV TRIGGERS: IMPORTANCE OF THE
Chair: Hugh Calkins, MD
11:30 – 12:15POSTERIOR LA
Amin Al-Ahmad, MD
 HOW TO INCORPORATE THE RESULTS OF THE CONVERGE TRIAL & THE EVOLUTION OF THE CONVERGENT APPROACH
David D. De Lurgio, MD, FACC, FHRS
 ARRHYTHMOGENESIS OF THE LAA: IMPACT OF THE AMAZE TRIAL
Suneet Mittal, MD
 FUTURE OF HYBRID APPROACHES
David J. Wilber, MD
Meet The Experts
0.75
ROLE OF NON-PV TRIGGERS: IMPORTANCE OF THE
Chair: Hugh Calkins, MD
11:30 – 12:15
POSTERIOR LA
Amin Al-Ahmad, MD
HOW TO INCORPORATE THE RESULTS OF THE CONVERGE TRIAL & THE EVOLUTION OF THE CONVERGENT APPROACH
David D. De Lurgio, MD, FACC, FHRS
ARRHYTHMOGENESIS OF THE LAA: IMPACT OF THE AMAZE TRIAL
Suneet Mittal, MD
FUTURE OF HYBRID APPROACHES
David J. Wilber, MD

Session 4

Chairs: Dhanunjaya “DJ” Lakkireddy, MD; Christopher McGann, MD

12:30 – 12:40EARLY AF-ABLATION IMPROVES OUTCOMES: MULTI-CENTER TRIALS
Oussama Wazni, MD
12:40 – 12:50PATHOPHYSIOLOGY OF THE THROMBOGENIC LEFT ATRIUM: TISSUE, SHAPE & FUNCTION
Nazem Akoum, MD
12:50 – 13:00HIGH POWER SHORT DURATION FOR AF: EFFICIENCY & SAFETY
Mihail G. Chelu, MD, PhD
13:00 – 13:10ATRIAL STRUCTURAL & FUNCTIONAL IMAGING FOR PREDICTING OUTCOMES IN AF
James Thomas, MD
13:10 – 13:30OPEN DISCUSSION
Session 4

Chairs: Dhanunjaya “DJ” Lakkireddy, MD; Christopher McGann, MD

12:30 – 12:40
EARLY AF-ABLATION IMPROVES OUTCOMES: MULTI-CENTER TRIALS
Oussama Wazni, MD
12:40 – 12:50
PATHOPHYSIOLOGY OF THE THROMBOGENIC LEFT ATRIUM: TISSUE, SHAPE & FUNCTION
Nazem Akoum, MD
12:50 – 13:00
HIGH POWER SHORT DURATION FOR AF: EFFICIENCY & SAFETY
Mihail G. Chelu, MD, PhD
13:00 – 13:10
ATRIAL STRUCTURAL & FUNCTIONAL IMAGING FOR PREDICTING OUTCOMES IN AF
James Thomas, MD
13:10 – 13:30
OPEN DISCUSSION

Session 5

CHAIRS: Tina Baykaner, MD, MPH; Mark Ibrahim, MD, FACC

13:30 – 13:40REFINING PATIENT SELECTION FOR AF ABLATION IN HF: RATIONALE FOR CASTLE-AF II
Nassir F. Marrouche, MD
13:40 – 13:50HOW DIGITAL HEALTH TOOLS ARE GLOBALIZING & IMPROVING AF SCREENING:
PATIENT PERSPECTIVES

Trudie C. A. Lobban, MBE, FRCP, Edin
13:50 – 14:00ATRIAL IMAGING USING CARDIAC MRI: OVERCOMING CHALLENGES
Eugene Kholmovski, PhD
14:00 – 14:10CARDIAC MRI FOR ATRIAL IMAGING IN AF: ESC GUIDELINES & SCALABILITY
Saman Nazarian, MD, PhD
14:10 – 14:20LIFESTYLE MODIFICATION IN AF GUIDELINES, BUT NOT IMPLEMENTED IN CLINICAL PRACTICE! WHY?
Prashanthan Sanders, MBBS, PhD
14:20 – 14:40OPEN DISCUSSION
14:40 – 14:55BREAK & EXHIBITS
Session 5

CHAIRS: Tina Baykaner, MD, MPH; Mark Ibrahim, MD, FACC

13:30 – 13:40
REFINING PATIENT SELECTION FOR AF ABLATION IN HF: RATIONALE FOR CASTLE-AF II
Nassir F. Marrouche, MD
13:40 – 13:50
HOW DIGITAL HEALTH TOOLS ARE GLOBALIZING & IMPROVING AF SCREENING: PATIENT PERSPECTIVES
Trudie C. A. Lobban, MBE, FRCP, Edin
13:50 – 14:00
ATRIAL IMAGING USING CARDIAC MRI: OVERCOMING CHALLENGES
Eugene Kholmovski, PhD
14:00 – 14:10
CARDIAC MRI FOR ATRIAL IMAGING IN AF: ESC GUIDELINES & SCALABILITY
Saman Nazarian, MD, PhD
14:10 – 14:20
LIFESTYLE MODIFICATION IN AF GUIDELINES, BUT NOT IMPLEMENTED IN CLINICAL PRACTICE! WHY?
Prashanthan Sanders, MBBS, PhD
14:20 – 14:40
OPEN DISCUSSION
14:40 – 14:55
BREAK & EXHIBITS

Session 6

CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD

14:55 – 15:05CARDIAC MRI, CTA OR TEE FOR LEFT ATRIAL APPENDAGE THROMBUS EVALUATION
Mark Ibrahim, MD, FACC
15:05 – 15:15SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2021
Francis E. Marchlinski, MD
15:15 – 15:25PHARMACOGENETIC TARGETING FOR AF PREVENTION IN AT-RISK HEART FAILURE PATIENTS
Michael R. Bristow, MD, PhD
15:25 – 15:35PILL-IN-THE-POCKET FOR AF STROKE PREVENTION: AVAILABLE EVIDENCE & FUTURE TRIALS
Rod Passman, MD, MSCE
15:35-15:55OPEN DISCUSSION
Session 6

CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD

14:55 – 15:05
CARDIAC MRI, CTA OR TEE FOR LEFT ATRIAL APPENDAGE THROMBUS EVALUATION
Mark Ibrahim, MD, FACC
15:05 – 15:15
SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2021
Francis E. Marchlinski, MD
15:15 – 15:25
PHARMACOGENETIC TARGETING FOR AF PREVENTION IN AT-RISK HEART FAILURE PATIENTS
Michael R. Bristow, MD, PhD
15:25 – 15:35
PILL-IN-THE-POCKET FOR AF STROKE PREVENTION: AVAILABLE EVIDENCE & FUTURE TRIALS
Rod Passman, MD, MSCE
15:35-15:55
OPEN DISCUSSION

Session 7

MODERATORS: Amin Al-Ahmad, MD; Jeanne E. Poole, MD

15:55 – 16:05ATRIAL FIBRILLATION ABLATION: NEW TOOLS & STRATEGIES FOR LESION CREATION & EVALUATION
Pierre Jais, MD
16:05 – 16:15DRONEDARONE BEYOND AF SUPPRESSION
Carina Blomstrom-Lundquist, MD, PhD
16:15 – 16:25MACHINE LEARNING APPROACHES FOR PPG INTERPRETATION: UNCOVERING HIDDEN SIGNALS
Chan Ho Lim, MS
16:25 – 16:35THE ESUS PATIENT: WHEN & HOW TO MONITOR FOR SUBCLINICAL AF
Suneet Mittal, MD
16:35 – 16:45APPLE HEART & HEARTLINE: HOW THESE TRIALS WILL CHANGE CLINICAL PRACTICE
Mintu Turakhia, MD
16:45 – 17:05OPEN DISCUSSION
Session 7

MODERATORS: Amin Al-Ahmad, MD; Jeanne E. Poole, MD

15:55 – 16:05
ATRIAL FIBRILLATION ABLATION: NEW TOOLS & STRATEGIES FOR LESION CREATION & EVALUATION
Pierre Jais, MD
16:05 – 16:15
DRONEDARONE BEYOND AF SUPPRESSION
Carina Blomstrom-Lundquist, MD, PhD
16:15 – 16:25
MACHINE LEARNING APPROACHES FOR PPG INTERPRETATION: UNCOVERING HIDDEN SIGNALS
Chan Ho Lim, MS
16:25 – 16:35
THE ESUS PATIENT: WHEN & HOW TO MONITOR FOR SUBCLINICAL AF
Suneet Mittal, MD
16:35 – 16:45
APPLE HEART & HEARTLINE: HOW THESE TRIALS WILL CHANGE CLINICAL PRACTICE
Mintu Turakhia, MD
16:45 – 17:05
OPEN DISCUSSION

Session 8

MODERATORS: John D. Day, MD

17:05 – 17:45ROUNDTABLE: ELECTROPHYSIOLOGY & DIGITAL HEALTH DURING A PANDEMIC:
HOW DID COVID-19 IMPACT MY CURRENT AND FUTURE CLINICAL PRACTICE?

Tina Baykaner, MD, MPH; Janet K. Han, MD; Christian Mahnkopf, MD; Suneet Mittal, MD
Session 8

MODERATORS: John D. Day, MD

17:05 – 17:45
ROUNDTABLE: ELECTROPHYSIOLOGY & DIGITAL HEALTH DURING A PANDEMIC: HOW DID COVID-19 IMPACT MY CURRENT AND FUTURE CLINICAL PRACTICE?
Tina Baykaner, MD, MPH; Janet K. Han, MD; Christian Mahnkopf, MD; Suneet Mittal, MD

Session 9

CHAIRS: Edward J. Schloss, MD, FHRS; Bassam Wanna, MD

17:45 -17:55NEW CLINICAL & COST BENEFITS OF EARLY AF TREATMENT
Karl Heinz Kuck, MD
17:55 – 18:05SAFETY, EFFECTIVENESS & CLINICAL BENEFITS OF PsAF TREATMENT USING CF RF ABLATION:
THE PRECEPT STUDY

Amin Al-Ahmad, MD
18:05 – 18:15THE SAFETY & EFFECTIVENESS OF PVI WITH STANDARDIZED ABLATION INDEX WORKFLOW (VISTAX)
Mattias Duytschaever, MD
18:15 – 18:25ADVANCES IN THE MANAGEMENT OF AF IN CONGESTIVE HEART FAILURE
Rakeesh Gopinathannair, MD, MA, FHRS
18:25 – 18:35ADOPTING A SAME-DAY DISCHARGE STRATEGY AFTER AF ABLATION: FEASIBILITY & SAFETY
Zayd Eldadah, MD
18:35 – 18:50OPEN DISCUSSION
18:50ADJOURNMENT
Session 9

CHAIRS: Edward J. Schloss, MD, FHRS; Bassam Wanna, MD

17:45 -17:55
NEW CLINICAL & COST BENEFITS OF EARLY AF TREATMENT
Karl Heinz Kuck, MD
17:55 – 18:05
SAFETY, EFFECTIVENESS & CLINICAL BENEFITS OF PsAF TREATMENT USING CF RF ABLATION: THE PRECEPT STUDY
Amin Al-Ahmad, MD
18:05 – 18:15
THE SAFETY & EFFECTIVENESS OF PVI WITH STANDARDIZED ABLATION INDEX WORKFLOW (VISTAX)
Mattias Duytschaever, MD
18:15 – 18:25
ADVANCES IN THE MANAGEMENT OF AF IN CONGESTIVE HEART FAILURE
Rakeesh Gopinathannair, MD, MA, FHRS
18:25 – 18:35
ADOPTING A SAME-DAY DISCHARGE STRATEGY AFTER AF ABLATION: FEASIBILITY & SAFETY
Zayd Eldadah, MD
18:35 – 18:50
OPEN DISCUSSION
18:50
ADJOURNMENT

Saturday, February 27, 2021

 

06:30 – 07:30CHECK-IN, EXHIBITS & BREAKFAST SNACKS

Saturday, February 27, 2021

 

06:30 – 07:30
CHECK-IN, EXHIBITS & BREAKFAST SNACKS

Session 10

CHAIRS: Thierry LeJemtel, MD; Andrea M. Russo, MD

07:30 – 07:40ENDURANCE TRAINING, AF & STROKE RISK: IS IT THE SAME TYPE OF REMODELING?
David Peritz, MD
07:40 – 07:50LAAO POST-PROCEDURAL ANTI-THROMBOTIC TREATMENT:
ASPIRIN, LOW-DOSE NOAC OR BOTH?

Vivek Reddy, MD
07:50 – 08:00IS OBESITY THE SOLE DRIVER BEHIND HFpEF LEADING TO AF?
Rohan Samson, MD
08:00- 08:10THE DIGITAL HEALTH REVOLUTION DURING COVID-19:
A HURDLE OR LONG-AWAITED CHANGE FOR AF PATIENTS?

Christine Albert, MD, MPH
08:10 – 08:20HEALTHY LIVES MATTER: WHAT COVID-19 HAS EXPOSED OF THE OVER WHELMING GLOBAL CRISIS IN PUBLIC HEALTH
Nicholas S. Peters, MD
08:20 – 08:40OPEN DISCUSSION
Session 10

CHAIRS: Thierry LeJemtel, MD; Andrea M. Russo, MD

07:30 – 07:40
ENDURANCE TRAINING, AF & STROKE RISK: IS IT THE SAME TYPE OF REMODELING?
David Peritz, MD
07:40 – 07:50
LAAO POST-PROCEDURAL ANTI-THROMBOTIC TREATMENT: ASPIRIN, LOW-DOSE NOAC OR BOTH?
Vivek Reddy, MD
07:50 – 08:00
IS OBESITY THE SOLE DRIVER BEHIND HFpEF LEADING TO AF?
Rohan Samson, MD
08:00- 08:10
THE DIGITAL HEALTH REVOLUTION DURING COVID-19: A HURDLE OR LONG-AWAITED CHANGE FOR AF PATIENTS?
Christine Albert, MD, MPH
08:10 – 08:20
HEALTHY LIVES MATTER: WHAT COVID-19 HAS EXPOSED OF THE OVER WHELMING GLOBAL CRISIS IN PUBLIC HEALTH
Nicholas S. Peters, MD
08:20 – 08:40
OPEN DISCUSSION

Session 11

MODERATORS: Nassir F. Marrouche, MD; Jeanne E. Poole, MD

08:40 – 09:05ROUNDTABLE: WHAT IS THE NEXT ABLATION RCT WE NEED THE MOST?
MOVING BEYOND CASTLE-AF, CABANA, AFFIRM AND EAST-AF

Johannes Brachmann, MD; Gerhard Hindricks, MD; Bradley P. Knight, MD; John Mandrola, MD;
Douglas L. Packer, MD
Session 11

MODERATORS: Nassir F. Marrouche, MD; Jeanne E. Poole, MD

08:40 – 09:05
ROUNDTABLE: WHAT IS THE NEXT ABLATION RCT WE NEED THE MOST? MOVING BEYOND CASTLE-AF, CABANA, AFFIRM AND EAST-AF
Johannes Brachmann, MD; Gerhard Hindricks, MD; Bradley P. Knight, MD; John Mandrola, MD;
Douglas L. Packer, MD

Session 12

MODERATORS: Christine Albert, MD, MPH; Frank Sachse, PhD

09:05 – 09:15STROKE & AF: TIME FOR A NEW RISK ASSESSMENT SCORE?
M. Edip Gurol, MD
09:15 – 09:25CHOOSING THE BEST AF ABLATION STRATEGY FOR EACH PATIENT: MY APPROACH
Andrea Natale, MD, FHRS, VACC, FESC
09:25 – 09:35THE IMPACT OF ABLATION LESIONS ON LA STRUCTURE & FUNCTION
Philipp Sommer, MD
09:35 – 09:45HOW TO PROTECT THE ESOPHAGUS DURING AF ABLATION
Emile Daoud, MD
09:45 – 09:55AF IN INHERITED ARRHYTHMIAS – A DIFFERENT BEAST?
Andrew Krahn, MD
09:55 – 10:10OPEN DISCUSSION
10:10 – 10:25BREAK & EXHIBITS
Session 12

MODERATORS: Christine Albert, MD, MPH; Frank Sachse, PhD

09:05 – 09:15
STROKE & AF: TIME FOR A NEW RISK ASSESSMENT SCORE?
M. Edip Gurol, MD
09:15 – 09:25
CHOOSING THE BEST AF ABLATION STRATEGY FOR EACH PATIENT: MY APPROACH
Andrea Natale, MD, FHRS, VACC, FESC
09:25 – 09:35
THE IMPACT OF ABLATION LESIONS ON LA STRUCTURE & FUNCTION
Philipp Sommer, MD
09:35 – 09:45
HOW TO PROTECT THE ESOPHAGUS DURING AF ABLATION
Emile Daoud, MD
09:45 – 09:55
AF IN INHERITED ARRHYTHMIAS – A DIFFERENT BEAST?
Andrew Krahn, MD
09:55 – 10:10
OPEN DISCUSSION
10:10 – 10:25
BREAK & EXHIBITS

Session 13

MODERATORS: Elaine M. Hylek, MD, MPH; Bassam Wanna, MD

10:25 – 11:05ROUNDTABLE: CHALLENGING DECISIONS IN ANTICOAGULATION THERAPY:
I WILL ANTICOAGULATE FOR STROKE PREVENTION WITHOUT PROOF OF AF IF……

Amin Al-Ahmad, MD; Thomas Deneke, MD; Greg Feld, MD; M. Edip Gurol, MD; Christopher McGann, MD
Session 13

MODERATORS: Elaine Hylek, MD; Bassam Wanna, MD

10:25 – 11:05
ROUNDTABLE: CHALLENGING DECISIONS IN ANTICOAGULATION THERAPY: I WILL ANTICOAGULATE FOR STROKE PREVENTION WITHOUT PROOF OF AF IF……
Amin Al-Ahmad, MD; Thomas Deneke, MD; Greg Feld, MD; M. Edip Gurol, MD; Christopher McGann, MD

Session 14

CHAIRS: T. Jared Bunch, MD; Rohan Samson, MD

11:05 – 11:15ADDRESSING KEY KNOWLEDGE GAPS IN THE AF & HF INTERACTION: RESEARCH PRIORITIES
TBC
11:15 – 11:25ELECTROPORATION IS CHANGING THE WAY WE WILL ABLATE AF
Moussa Mansour, MD
11:25 – 11:35I STOP OAC AFTER ABLATION OF AF IF….
David J. Callans, MD
11:35 – 11:45TARGETING FIBROSIS IN AF ABLATION: THE DECAAF TRIALS
David J. Wilber, MD
11:45 – 11:55ABLATE & CLOSE THE LEFT ATRIAL APPENDAGE: PATIENT SELECTION
Dhanunjaya “DJ” Lakkireddy, MD
11:55 – 12:10OPEN DISCUSSION
12:10 – 13:10LUNCH & EXHIBITS
12:20 – 13:05MEET THE EXPERTS
Session 14

CHAIRS: T. Jared Bunch, MD; Rohan Samson, MD

11:05 – 11:15
ADDRESSING KEY KNOWLEDGE GAPS IN THE AF & HF INTERACTION: RESEARCH PRIORITIES
TBC
11:15 – 11:25
ELECTROPORATION IS CHANGING THE WAY WE WILL ABLATE AF
Moussa Mansour, MD
11:25 – 11:35
I STOP OAC AFTER ABLATION OF AF IF….
David J. Callans, MD
11:35 – 11:45
TARGETING FIBROSIS IN AF ABLATION: THE DECAAF TRIALS
David J. Wilber, MD
11:45 – 11:55
ABLATE & CLOSE THE LEFT ATRIAL APPENDAGE: PATIENT SELECTION
Dhanunjaya “DJ” Lakkireddy, MD
11:55 – 12:10
OPEN DISCUSSION
12:10 – 13:10
LUNCH & EXHIBITS
12:20 – 13:05
MEET THE EXPERTS

Session 15

CHAIRS: Dhiraj Gupta, FRCP, MD; Oussama Wazni, MD

13:10 – 13:20FACTOR XI FOR STROKE PREVENTION: HOPE OR HYPE?
Elaine M. Hylek, MD, MPH
13:20 – 13:30PAROXYSMAL, PERSISTENT & LONG-STANDING AF: TIME FOR A NEW CLASSIFICATION
Jason Andrade, MD
13:30 – 13:40EPI-CARDIAL BRIDGING & EPI-ENDO DISSOCIATION
Roderick Tung, MD
13:40 – 13:50ATRIAL FIBRILLATION & ATRIAL FLUTTER: DIFFERENCE IN REMODELING PROCESSES
Sanjiv M. Narayan, MD, PhD
13:50 – 14:00I USE DIGITAL HEALTH DEVICES FOR DETECTION OF AF IN MY PATIENTS, BUT……
David McManus, MD
14:00 – 14:20OPEN DISCUSSION
Session 15

CHAIRS: Dhiraj Gupta, FRCP, MD; Oussama Wazni, MD

13:10 – 13:20
FACTOR XI FOR STROKE PREVENTION: HOPE OR HYPE?
Elaine M. Hylek, MD, MPH
13:20 – 13:30
PAROXYSMAL, PERSISTENT & LONG-STANDING AF: TIME FOR A NEW CLASSIFICATION
Jason Andrade, MD
13:30 – 13:40
EPI-CARDIAL BRIDGING & EPI-ENDO DISSOCIATION
Roderick Tung, MD
13:40 – 13:50
ATRIAL FIBRILLATION & ATRIAL FLUTTER: DIFFERENCE IN REMODELING PROCESSES
Sanjiv M. Narayan, MD, PhD
13:50 – 14:00
I USE DIGITAL HEALTH DEVICES FOR DETECTION OF AF IN MY PATIENTS, BUT……
David McManus, MD
14:00 – 14:20
OPEN DISCUSSION

Session 16

CHAIRS: Jason Andrade, MD; Mikhael El Chami, MD

14:20 – 14:30MY MAZE PROCEDURE IN 2021
Ralph J. Damiano, Jr., MD
14:30 – 14:40CLOSING THE APPENDAGE FOR PERSISTENT LAA CLOT
Rahul N. Doshi, MD
14:40 – 14:50WEARABLES IN EP: HRS GUIDANCE DOCUMENT
Hamid Ghanbari, MD, MPH
14:50 – 15:00COMBINING CARDIAC MRI & ARTIFICIAL INTELLIGENCE FOR PREDICTION OF ABLATION OUTCOMES
Natalia Trayanova, PhD, FHRS, FAHA
15:00 – 15:10ATRIAL FIBROSIS PREDICTS AF OCCURRENCE: INSIGHTS FROM ATRIAL MR IMAGING
Brent D. Wilson, MD, PhD
15:10 – 15:30OPEN DISCUSSION
15:30 – 15:50BREAK & EXHIBITS
Session 16

CHAIRS: Jason Andrade, MD; Mikhael El Chami, MD

14:20 – 14:30
MY MAZE PROCEDURE IN 2021
Ralph J. Damiano, Jr., MD
14:30 – 14:40
CLOSING THE APPENDAGE FOR PERSISTENT LAA CLOT
Rahul N. Doshi, MD
14:40 – 14:50
WEARABLES IN EP: HRS GUIDANCE DOCUMENT
Hamid Ghanbari, MD, MPH
14:50 – 15:00
COMBINING CARDIAC MRI & ARTIFICIAL INTELLIGENCE FOR PREDICTION OF ABLATION OUTCOMES
Natalia Trayanova, PhD, FHRS, FAHA
15:00 – 15:10
ATRIAL FIBROSIS PREDICTS AF OCCURRENCE: INSIGHTS FROM ATRIAL MR IMAGING
Brent Wilson, MD
15:10 – 15:30
OPEN DISCUSSION
15:30 – 15:50
BREAK & EXHIBITS

Session 17

CHAIRS: Janet K. Han, MD, FACC, FHRS; Jonathan Hsu, MD

15:50 – 16:00REVERSE ATRIAL REMODELING AFTER ATRIAL FIBRILLATION ABLATION
Dhiraj Gupta, FRCP
16:00 – 16:10HOW I APPROACH MY RE-DO AF ABLATION PROCEDURE
Lluis Mont, MD
16:10 – 16:20THE MECHANISMS BEHIND AF & COGNITIVE IMPAIRMENT
T. Jared Bunch, MD
16:20 – 16:30LAA AS A THERAPEUTIC TARGET FOR AF
Randall J. Lee, MD
16:30 – 16:40PACS AND AF: CAUSE OR CONSEQUENCE?
Edward P. Gerstenfeld, MD
16:40 – 17:00OPEN DISCUSSION
Session 17

CHAIRS: Janet K. Han, MD, FACC, FHRS; Jonathan Hsu, MD

15:50 – 16:00
REVERSE ATRIAL REMODELING AFTER ATRIAL FIBRILLATION ABLATION
Dhiraj Gupta, FRCP
16:00 – 16:10
HOW I APPROACH MY RE-DO AF ABLATION PROCEDURE
Lluis Mont, MD
16:10 – 16:20
THE MECHANISMS BEHIND AF & COGNITIVE IMPAIRMENT
T. Jared Bunch, MD
16:20 – 16:30
LAA AS A THERAPEUTIC TARGET FOR AF
Randall J. Lee, MD
16:30 – 16:40
PACS AND AF: CAUSE OR CONSEQUENCE?
Edward P. Gerstenfeld, MD
16:40 – 17:00
OPEN DISCUSSION

Session 18

MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS

17:00 – 18:00ROUNDTABLE: #ASKWAF: TBA (Twitter Questions)
Alexandru Costea, MD; John D. Day, MD; Debbe McCall, MBA; 
Leenhapong Navaravouong, MD; Christina J. Wurster, MBA
18:00ADJOURNMENT
Session 18

MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS

17:00 – 18:00
ROUNDTABLE: #ASKWAF: TBA (Twitter Questions)
Alexandru Costea, MD; John D. Day, MD; Debbe McCall, MBA;
Leenhapong Navaravouong, MD; Christina J. Wurster, MBA
18:00
ADJOURNMENT